Galectin Therapeutics Inc (NASDAQ:GALT)

3.69
Delayed Data
As of 3:59pm ET
 +0.12 / +3.36%
Today’s Change
3.00
Today|||52-Week Range
18.62
+6.34%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
AssetsCash----9.4M10.5M
 
 
 
Short Term Investment Cash5.6M506.0K3.0M1.1M
 
 
 
 
 
Cash & Short Term Investments5.9M6.4M9.4M10.5M
 
 
 
 
 
 
ReceivablesReceivables234.0K0.000.000.00
 
 
 
InventoriesInventories0.000.000.00----
 
Current AssetsPrepaid Expenses----153.0K--
 
 
Other Current Assets70.0K104.0K0.00198.0K
 
 
 
 
Current Assets6.2M6.5M9.5M10.7M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross316.0K321.0K74.0K74.0K
 
 
 
 
 
Depreciation-309.0K-315.0K-66.0K-71.0K
 
 
 
 
 
Intangible Assets39.0K36.0K30.0K23.0K
 
 
 
 
 
Other Assets39.0K36.0K30.0K23.0K
 
 
 
 
 
Total Assets6.3M6.6M9.6M10.7M
 
 
 
 
 
 
LiabilitiesAccounts Payable125.0K384.0K397.0K762.0K
 
 
 
 
 
Accrued Expenses450.0K1.2M1.1M1.1M
 
 
 
 
 
Other Current Liabilities1.3M1.4M1.1M1.1M
 
 
 
 
 
Other Liabilities1.6M2.2M1.6M2.5M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities12.0K0.006.0K0.00
 
 
 
Total Liabilities1.8M2.2M1.6M2.5M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock6.9M7.2M7.4M7.3M
 
 
 
 
 
Common Equity-2.3M-2.8M533.0K894.0K
 
 
 
 
 
Total Shareholder Equity4.5M4.4M7.9M8.2M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding10.7M12.9M16.1M18.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account